S, D. Et Al. 2019. Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.. Clinical and experimental rheumatology , vol.38, no.3 , 552-557.

S, D., O, S., Y, B., E, S., Um, S., B, B., ... Be, S.(2019). Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.. Clinical and experimental rheumatology , vol.38, no.3, 552-557.

S, SELCAN Et Al. "Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.," Clinical and experimental rheumatology , vol.38, no.3, 552-557, 2019

S, SELCAN Et Al. "Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.." Clinical and experimental rheumatology , vol.38, no.3, pp.552-557, 2019

S, D. Et Al. (2019) . "Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.." Clinical and experimental rheumatology , vol.38, no.3, pp.552-557.

@article{article, author={SELCAN DEMİR Et Al. }, title={Desensitisation overcomes rituximab- and tocilizumab-related immediate hypersensitivity in childhood.}, journal={Clinical and experimental rheumatology}, year=2019, pages={552-557} }